Cardile Anthony P, Woodbury Ronald L, Sanchez Carlos J, Becerra Sandra C, Garcia Rebecca A, Mende Katrin, Wenke Joseph C, Akers Kevin S
Infectious Disease Service, Department of Medicine, San Antonio Military Medical Center, JBSA Fort Sam Houston, San Antonio, TX, USA.
Extremity Trauma and Regenerative Medicine Task Area, United States Army Institute of Surgical Research, JBSA Fort Sam Houston, San Antonio, TX, USA.
Adv Exp Med Biol. 2017;973:53-70. doi: 10.1007/5584_2016_93.
Biofilm formation is a major virulence factor for numerous pathogenic bacteria and is cited as a central event in the pathogenesis of chronic human infections, which is in large part due to excessive extracellular matrix secretion and metabolic changes that occur within the biofilm rendering them highly tolerant to antimicrobial treatments. Polyamines, including norspermidine, play central roles in bacterial biofilm development, but have also recently been shown to inhibit biofilm formation in select strains of various pathogenic bacteria. The aim of this study was to evaluate in vitro the biofilm dispersive and inhibitory activities of norspermidine against multidrug-resistant clinical isolates of Acinetobacter baumannii(n = 4), Klebsiella pneumoniae (n = 3), Pseudomonas aeruginosa (n = 5) and Staphylococcus aureus (n = 4) associated with chronic extremity wound infections using the semi-quantitative 96-well plate method and confocal laser microscopy. In addition to the antibiofilm activity, biocompatibility of norspermidine was also evaluated by measuring toxicity in vitro to human cell lines and whole porcine tissue explants using MTT viability assay and histological analysis. Norspermidine (5-20 mM) had variable dispersive and inhibitory activity on biofilms which was dependent on both the strain and species. Of the clinical bacterial species evaluated herein, A. baumannii isolates were the most sensitive to the effect of norspermidine, which was in part due to the inhibitory effects of norspermidine on bacterial motility and expression of genes involved in the production of homoserine lactones and quorum sensing molecules both essential for biofilm formation. Importantly, exposure of cell lines and whole tissues to norspermidine for prolonged periods of time (≥24 h) was observed to reduce viability and alter tissue histology in a time and concentration dependent manner, with 20 mM exposure having the greatest negative effects on both tissues and individual cell lines. Collectively our findings demonstrate that, similar to other polyamines, norspermidine displays both inhibitory and dispersive activities on biofilms of clinical multidrug-resistant bacterial isolates, in particular for strains of A. baumannii. Additionally our findings suggest that direct application may be considered on tissues, albeit for limited exposure times.
生物膜形成是许多病原菌的主要毒力因子,被认为是人类慢性感染发病机制中的核心事件,这在很大程度上归因于生物膜内过量的细胞外基质分泌和代谢变化,使其对抗菌治疗具有高度耐受性。包括亚精胺在内的多胺在细菌生物膜形成中起核心作用,但最近也显示出对各种病原菌的某些菌株的生物膜形成具有抑制作用。本研究的目的是使用半定量96孔板法和共聚焦激光显微镜,在体外评估亚精胺对与慢性肢体伤口感染相关的鲍曼不动杆菌(n = 4)、肺炎克雷伯菌(n = 3)、铜绿假单胞菌(n = 5)和金黄色葡萄球菌(n = 4)的多药耐药临床分离株的生物膜分散和抑制活性。除了抗生物膜活性外,还通过使用MTT活力测定法和组织学分析来测量亚精胺对人细胞系和全猪组织外植体的体外毒性,从而评估亚精胺的生物相容性。亚精胺(5-20 mM)对生物膜具有可变的分散和抑制活性,这取决于菌株和菌种。在本文评估的临床细菌种类中,鲍曼不动杆菌分离株对亚精胺的作用最敏感,部分原因是亚精胺对细菌运动性以及对生物膜形成至关重要的高丝氨酸内酯和群体感应分子产生相关基因表达的抑制作用。重要的是,观察到细胞系和全组织长时间(≥24小时)暴露于亚精胺会以时间和浓度依赖性方式降低活力并改变组织组织学,20 mM的暴露对组织和单个细胞系的负面影响最大。我们的研究结果共同表明,与其他多胺类似,亚精胺对临床多药耐药细菌分离株的生物膜具有抑制和分散活性,特别是对鲍曼不动杆菌菌株。此外,我们的研究结果表明,尽管暴露时间有限,但可以考虑将其直接应用于组织。